Clean air trial hopes to ease breathing for rare lung disease patients
NCT ID NCT07417267
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether using HEPA air purifiers at home can reduce respiratory symptoms and improve lung function in children and adults with Cystic Fibrosis (CF) or Primary Ciliary Dyskinesia (PCD). Participants will have two purifiers installed in their home and will undergo lung function tests and symptom checks over several months. The goal is to see if cleaner indoor air makes a real difference in their daily breathing and overall health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical School, University of Cyprus
Nicosia, Aglantzia, 2029, Cyprus
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we spot hidden muscle loss in kids with a rare lung condition?
- Do kids with a rare lung condition face hidden muscle loss?
- Breathing vs. beating: which technique clears lungs better in cystic fibrosis?
- Could modern CF drugs make daily inhaled treatments obsolete?
- New study investigates hidden heart risks in cystic fibrosis patients on modern drugs
- Blood pressure drug may help preserve insulin in cystic fibrosis